Press release
Adrenal crisis Market on Track for Major Expansion by 2034, According to DelveInsight | Takeda Pharma, Sandoz International GmbH, Pfizer Inc, Bristol-Myers Squibb, Merck KGaA, Antares Pharma
DelveInsight's "Adrenal crisis Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Adrenal crisis, historical and forecasted epidemiology as well as the Adrenal crisis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.To Know in detail about the Adrenal crisis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Adrenal crisis Market Forecast
https://www.delveinsight.com/sample-request/adrenal-crisis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Adrenal crisis Market Report:
• The Adrenal crisis market size was valued approximately USD 11.5 Million in 2022 and is anticipated to grow with a significant CAGR during the study period (2020-2034)
• It is estimated that around 6-8% of patients diagnosed with adrenal insufficiency experience an adrenal crisis annually.
• According to the analysis, over 400 patients with Adrenal Insufficiency experience approximately 8 adrenal crises per 100 patient-years.
• The observed prevalence rates among the patient population are around 38% for primary adrenal insufficiency, 57% for secondary adrenal insufficiency, and 6% for congenital adrenal hyperplasia (CAH). Additionally, conventional hydrocortisone replacement therapy is expected to be more frequently used than prednisolone, with dexamethasone being the least commonly utilized.
• Key Adrenal crisis Companies: Pfizer Inc., Takeda Pharmaceutical, Sandoz International GmbH, Pfizer Inc, Bristol-Myers Squibb, Merck KGaA, Antares Pharma, Mallinckrodt Pharmaceutical, Mylan Pharmaceutical, AG eTon Pharmaceuticals, and others
• Key Adrenal crisis Therapies: SOLU-CORTEF, ATRS-1902, and others
• The Adrenal crisis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Adrenal crisis pipeline products will significantly revolutionize the Adrenal crisis market dynamics.
Adrenal crisis Overview
An adrenal crisis, also known as an acute adrenal crisis or adrenal insufficiency crisis, is a life-threatening medical emergency that occurs when the adrenal glands fail to produce an adequate amount of cortisol, a vital hormone responsible for regulating various bodily functions, particularly in times of stress. Adrenal crisis typically occurs in individuals with underlying adrenal insufficiency, such as those with Addison's disease or individuals who have undergone bilateral adrenalectomy.
Get a Free sample for the Adrenal crisis Market Report:
https://www.delveinsight.com/report-store/adrenal-crisis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Adrenal crisis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Adrenal crisis Epidemiology Segmentation:
The Adrenal crisis market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Adrenal crisis
• Prevalent Cases of Adrenal crisis by severity
• Gender-specific Prevalence of Adrenal crisis
• Diagnosed Cases of Episodic and Chronic Adrenal crisis
Download the report to understand which factors are driving Adrenal crisis epidemiology trends @ Adrenal crisis Epidemiology Forecast
https://www.delveinsight.com/sample-request/adrenal-crisis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Adrenal crisis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Adrenal crisis market or expected to get launched during the study period. The analysis covers Adrenal crisis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Adrenal crisis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Adrenal crisis Therapies and Key Companies
• SOLU-CORTEF: Pfizer Inc.
• ATRS-1902: Antares Pharma
Discover more about therapies set to grab major Adrenal crisis market share @ Adrenal crisis Treatment Market
https://www.delveinsight.com/sample-request/adrenal-crisis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Scope of the Adrenal crisis Market Report
• Study Period: 2020-2034
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Adrenal crisis Companies: Pfizer Inc., Takeda Pharmaceutical, Sandoz International GmbH, Pfizer Inc, Bristol-Myers Squibb, Merck KGaA, Antares Pharma, Mallinckrodt Pharmaceutical, Mylan Pharmaceutical, AG eTon Pharmaceuticals, and others
• Key Adrenal crisis Therapies: SOLU-CORTEF, ATRS-1902, and others
• Adrenal crisis Therapeutic Assessment: Adrenal crisis current marketed and Adrenal crisis emerging therapies
• Adrenal crisis Market Dynamics: Adrenal crisis market drivers and Adrenal crisis market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Adrenal crisis Unmet Needs, KOL's views, Analyst's views, Adrenal crisis Market Access and Reimbursement
To know more about Adrenal crisis companies working in the treatment market, visit @ Adrenal crisis Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/adrenal-crisis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1. Adrenal crisis Market Report Introduction
2. Executive Summary for Adrenal crisis
3. SWOT analysis of Adrenal crisis
4. Adrenal crisis Patient Share (%) Overview at a Glance
5. Adrenal crisis Market Overview at a Glance
6. Adrenal crisis Disease Background and Overview
7. Adrenal crisis Epidemiology and Patient Population
8. Country-Specific Patient Population of Adrenal crisis
9. Adrenal crisis Current Treatment and Medical Practices
10. Adrenal crisis Unmet Needs
11. Adrenal crisis Emerging Therapies
12. Adrenal crisis Market Outlook
13. Country-Wise Adrenal crisis Market Analysis (2020-2034)
14. Adrenal crisis Market Access and Reimbursement of Therapies
15. Adrenal crisis Market Drivers
16. Adrenal crisis Market Barriers
17. Adrenal crisis Appendix
18. Adrenal crisis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Related Reports:
Adrenal crisis Epidemiology https://www.delveinsight.com/report-store/adrenal-crisis-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Adrenal crisis Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Adrenal crisis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports by DelveInsight
• Artificial Kidney Market: https://www.delveinsight.com/report-store/artificial-kidney-market
• Cardiac Rhythm Management Devices Market: https://www.delveinsight.com/report-store/cardiac-rhythm-management-devices-market
• Tumor Ablation Market: https://www.delveinsight.com/report-store/tumor-ablation-market
• Fibromyalgia Market: https://www.delveinsight.com/report-store/fibromyalgia-market
• Vascular Access Devices Market: https://www.delveinsight.com/report-store/vascular-access-device-market
• India Healthcare Report: https://www.delveinsight.com/report-store/india-healthcare-outlook-report
• Implantable Cardioverter Defibrillators Market: https://www.delveinsight.com/report-store/defibrillator-market
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Adrenal crisis Market on Track for Major Expansion by 2034, According to DelveInsight | Takeda Pharma, Sandoz International GmbH, Pfizer Inc, Bristol-Myers Squibb, Merck KGaA, Antares Pharma here
News-ID: 3835390 • Views: …
More Releases from DelveInsight Business Research
Anti-CD19 Antibody Pipeline 2025: Therapies Under Investigation, Clinical Trials …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Anti-CD19 Antibody pipeline constitutes 12+ key companies continuously working towards developing 12+ Anti-CD19 Antibody treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Anti-CD19 Antibody Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Anti-CD19 Antibody Market.
The Anti-CD19…
EGFR Non Small Cell Lung Cancer Pipeline 2025: MOA and ROA Insights, Clinical Tr …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, EGFR Non Small Cell Lung Cancer pipeline constitutes 25+ key companies continuously working towards developing 30+ EGFR Non Small Cell Lung Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The EGFR Non Small Cell Lung Cancer Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products…
Intrahepatic Cholangiocarcinoma Pipeline 2025: FDA Updates, Therapy Innovations, …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, Intrahepatic Cholangiocarcinoma pipeline constitutes 18+ key companies continuously working towards developing 20+ Intrahepatic Cholangiocarcinoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Intrahepatic Cholangiocarcinoma Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report…
Atopic Dermatitis Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Ev …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Atopic Dermatitis pipeline constitutes 100+ key companies continuously working towards developing 120+ Atopic Dermatitis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Atopic Dermatitis Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also…
More Releases for Adrenal
Adrenal Insufficiency Market to Reach USD 4.03 Billion by 2034
Pune, India - December 2025 - The global Adrenal Insufficiency Market, valued at USD 2.38 billion in 2024, is projected to reach USD 4.03 billion by 2034, growing at a 5.4% CAGR (2025-2034), according to Exactitude Consultancy. Rising prevalence of autoimmune disorders, enhanced diagnostic awareness, and advancements in glucocorticoid replacement therapies are fueling consistent market growth.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72005
Market Summary
The Adrenal Insufficiency Market is…
Adrenal crisis Market Insights Highlight Expanding Outlook Till 2034, DelveInsig …
DelveInsight's "Adrenal crisis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Adrenal crisis, historical and forecasted epidemiology as well as the Adrenal crisis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Adrenal crisis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Adrenal crisis Market Forecast
https://www.delveinsight.com/sample-request/adrenal-crisis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Rising Cigarette Smoking Boost The Adrenal Cancer: Key Factor Driving The Growth …
The Adrenal Cancer Diagnostics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Adrenal Cancer Diagnostics Market Size During the Forecast Period?
Over the past few years, the market size for adrenal cancer diagnostics has been experiencing strong growth. It is projected to…
Congenital Adrenal Hyperplasia Treatment Market Report and Forecast 2024-2032
The congenital adrenal hyperplasia treatment market size was valued at USD 422.9 million in 2023, driven by increasing government funding and assistance along with joint research. The market size is anticipated to grow at a CAGR of 8.10% during the forecast period of 2024-2032 to achieve a value of USD 852.42 million by 2032.
Congenital Adrenal Hyperplasia Treatment: Introduction
Congenital Adrenal Hyperplasia (CAH) treatment typically involves lifelong replacement of deficient hormones. For…
Addison's Disease Testing: Diagnostic Approaches for Unveiling Adrenal Insuffici …
Addison Disease Testing Market 2023 Forecast: Unveiling Opportunities and Growth
Addison Disease Testing Market research report helps to recognize the market challenges and opportunities. Global Addison Disease Testing Market report contains the recent forecast research for the predicted period. The report extensively offers the latest information about the technological developments and market growth prospect on the basis of the regional landscape. This Report offers a complete evaluation of every area including…
Adrenal Insufficiency Market to Witness Growth by 2032, estimates DelveInsight
DelveInsight's "Adrenal Insufficiency Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Adrenal Insufficiency, historical and forecasted epidemiology as well as the Adrenal Insufficiency market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Adrenal Insufficiency market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Adrenal Insufficiency market size…
